期刊文献+

二甲双胍在喉癌Hep-2细胞中对5-氟尿嘧啶、顺铂、紫杉醇的作用及机制探讨 被引量:4

Metformin's effect on 5-fluorouracil,cisplatin,paclitaxel in laryngocarcinoma Hep-2 cells
原文传递
导出
摘要 目的:检测5-氟尿嘧啶联合二甲双胍对喉癌Hep-2细胞增殖抑制作用及化疗敏感影响。探究二甲双胍联合顺铂、紫杉醇、5-氟尿嘧啶作用于Hep-2细胞AMPK通路信号分子的表达变化。方法:体外培养Hep-2细胞,二甲双胍联合5-氟尿嘧啶作用细胞72h,MTT检测增殖情况。二甲双胍联合顺铂、5-氟尿嘧啶、紫杉醇作用细胞72h,Western blot检测P21、Cyclin D1、AMPK-α表达。结果:5-氟尿嘧啶以及二甲双胍可抑制Hep-2细胞增殖。二甲双胍联合低浓度5-氟尿嘧啶,细胞生长抑制率升高;二甲双胍联合高浓度5-氟尿嘧啶生长抑制率无明显差异,两药在Hep-2细胞中相互拮抗。Western blot显示,顺铂、5-氟尿嘧啶增加细胞中上述蛋白表达,紫杉醇减少细胞中Cyclin D1表达。对比单独用药组,联用二甲双胍均引起Hep-2细胞中上述蛋白表达变化。结论:5-氟尿嘧啶抑制Hep-2细胞增殖,二甲双胍拮抗5-氟尿嘧啶对Hep-2细胞抗肿瘤效应,其拮抗作用及对顺铂、紫杉醇的影响部分通过AMPK、P21及Cyclin D1相关通路发生作用且与周期阻滞存在密切关系。 Objective:To investigate metformin's effect on chemosensitivity of chemotherapeutic drug 5-fluorouracil in laryngocarcinoma Hep-2cells.Investigate the variation trend of protein expression of AMPK pathway in the combined effect.Method:Laryngocarcinoma Hep-2cells were treated with different concentrations of 5-fluorouracil in vitro together with or without metformin for 72 h.Use MTT assay to investigate the influence on the inhibition rate to Hep-2cells.Hep-2cells were treated with cisplatin,5-fluorouracil or paclitaxel with or without metformin.Use Western blot assay to investigate the expression level of AMPKα,P21 or Cyclin D1 protein.Result:5-fluorouracil and metformin could inhibit the proliferation of Hep-2cells.5-fluorouracil in low concentration combined with metformin could increase the proliferation inhibition rate of Hep-2cells.In the circumstances of using 5-fluorouracil in high concentration with metformin,the cell proliferation inhibition rate of combining group makes no differences with the single-drug group.The combination of metformin and 5-fluorouracil produced an antagonism action in Hep-2cells.Western blot assay showed that metformin,cisplatin,5-fluorouracil could have caused the increase of expression level of AMPK-α,P21 and Cyclin D1 in Hep-2cells while Paclitaxel could have cause the decrease of expression level of Cyclin D1.Using combined drug could cause the change of protein expression.Conclusion:5-fluorouracil has been found to inhibit the proliferation of Hep-2cells.Metformin has an antagonism on the anticancer effect to 5-fluorouracil in Hep-2cells,and this antagonistic effect occurred partially through molecular signal pathways of AMPK-α,P21 and Cyclin D1 and it's significantly related to the cell cycle arrest.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2017年第7期524-528,共5页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 二甲双胍 喉肿瘤 一磷酸腺苷活化蛋白激酶 CYCLIN D1 P21 metformin laryngeal neoplasms AMPK Cyclin D1 P21
  • 相关文献

参考文献4

二级参考文献86

  • 1Valter Donadon,Massimiliano Balbi,Francesca Valent,Angelo Avogaro.Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma[J].World Journal of Gastroenterology,2010,16(24):3025-3032. 被引量:15
  • 2李章芳,沈洁.二甲双胍对肿瘤抑制作用的研究进展[J].中华临床医师杂志(电子版),2011,5(17):5081-5083. 被引量:5
  • 3Keereweer S, Kerrebijn JD, A1-Mamgani A, et al.Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life [ J ]. Eur Arch Otorhinolaryngol, 2011, 269 (3) :939-946.
  • 4Suh S, Kim KW. Diabetes and cancer:is diabetes causally related to cancer? [J]. Diabetes Metabolism J, 2011, 35(3) :193-198.
  • 5Drzewoski J, Drozdowska A, S liwinska A. Do we have enough data to confirm the link between antidiabetic drug use and cancer development? [J]. Pol Arch Med Wewn, 2011, 121 (3):81- 87.
  • 6Dowling RJ, Goodwin PJ, Stambolic V. Understanding the benefit of metformin use in cancer treatment[J]. BMC Med, 2011, 9: 33.
  • 7Green AS, Chapuis N, Lacombe C, et al. LKB1/AMPK/mTOR signaling pathway in hematological malignancies : From metabolism to cancer cell biology [ J ]. Cell Cycle, 2011, 10 ( 13 ) : 2115- 2120.
  • 8Shaw RJ. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth[ J]. Acta Physiologica, 2009, 196 ( 1 ) :65-80.
  • 9Yuan HD, Yuan HY, Chung SH, et al. An active part of artemisia sacrorum Ledeb. attenuates hepatic lipid accumulation through activating AMP-activated protein kinase in human HepG2 ceIIs[J]. Biosci Biotechnol Biochem, 2010, 74(2):322-328.
  • 10Luo Z, Zang M, Guo W. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth [ J ]. Future Oncol, 2010, 6 (3) :457-470.

共引文献25

同被引文献26

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部